IMC responds to final report of Advisory Council on the Implementation of National Pharmacare
June 12, 2019
The recommendations put forward today […]
The recommendations put forward today […]
Ottawa, June 3, 2019 – Innovative Medicines Canada (IMC) expressed its disappointment in the Government of British Columbia’s recent decision to force patients to switch from originator biologic therapies to […]
Montreal, March 21, 2019 – In response to the budget tabled by Quebec’s Finance Minister, Éric Girard, Innovative Medicines Canada (IMC) welcomes the first budget of the new Quebec government, […]
IMC welcomes the measures taken in Budget 2019 […]
Ottawa, November 21, 2018 The following statement can be attributed to Innovative Medicines Canada President, Pamela Fralick. “As a driver of innovation, the innovative pharmaceutical industry welcomes the targeted measures […]
IMC welcomes ISED roundtable recommendations […]
Ottawa, July 3, 2018 – Innovative Medicines Canada congratulates the new Ontario Minister of Health and Long-Term Care, Christine Elliott, on moving decisively to revamp OHIP+. “It’s a win-win for […]
Ottawa, April 19, 2018 – The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada. “Innovative Medicines Canada agrees with the House of Commons Standing Committee on […]
Ottawa, April 12, 2018 – The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada. “All members of Innovative Medicines Canada are bound by the association’s Code of […]
Montreal, March 27, 2018 – In response to the budget tabled by Quebec Finance Minister Carlos Leitão, Innovative Medicines Canada welcomes investment to support the innovative life sciences sector in […]
